The increase in anti-mitochondrial autoantibodies (AMAs), a typical immune signature of PBC patients, targets the PDC-E2 in cholangiocytes, causing the apoptosis of biliary epithelial cells and thereby hampering the physiological architecture of small and medium intrahepatic bile ducts [18]. This evidence concerns the gene DLAT and primary biliary cholangitis.